Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny
Jun 11, 2025
by Prosper Junior Bakiny
Does This News Make Meta Platforms Stock a Buy?
Jun 8, 2025
by Prosper Junior Bakiny
1 Stock Down 34% This Year to Buy and Hold
Jun 5, 2025
by Prosper Junior Bakiny
2 Recession-Proof Stocks to Buy and Hold
Jun 5, 2025
by Prosper Junior Bakiny
2 Soaring Stocks Wth More Upside Potential
Jun 1, 2025
by Prosper Junior Bakiny
Terrible News for Pfizer Stock Investors
Jun 1, 2025
by Prosper Junior Bakiny
2 Top Stocks to Buy Right Now
May 31, 2025
by Prosper Junior Bakiny
Does This Move Make Medtronic Stock a Buy?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.